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Comparison of hemodynamic and 
sympatho neural responses to adenosine 
and lower body negative pressure in man
Gerard A. Rongen, Beverley L. Senn, Shin-ichi Ando, Catherine F. Notarius, 
Janies A. Stone, and John S. Floras
Abstract: Adenosine increases heart rate and sympathetic nerve activity reflexively in conscious humans through several 
mechanisms. The purpose of this study was to assess the relative contributions of arterial baroreceptor unloading, carotid 
chemoreceptor stimulation, and other adenosine-sensitive afferent nerves to these responses. In 12 healthy men, the effect on 
blood pressure, heart rate (HR), and muscle sympathetic nerve activity (MSNA; peroneal nerve) of lower body negative 
pressure (LBNP; -15 mmHg (1 mmHg =133.3 Pa)) was compared with the effect of intravenous adenosine (35, 70, and 
140 |ag*kg"1*min_1). In eight subjects, the highest dose was reinfused during 100% oxygen to suppress arterial chemoreceptors. 
Blood pressure reductions during LBNP and adenosine (140 jxg-kg'^min“1) were similar. HR did not change significantly 
during LBNP (+2 ± 2 beats/min; mean ± SE) but increased at the highest adenosine dose (+25 ± 3 beats/min; p  < 0.05).
MSNA increased significantly (p < 0.05) during both interventions (+255 ± 82 and +247 ±58 units/100 beats for adenosine 
and LBNP, respectively), and there was no difference in the MSNA response to these two stimuli (p > 0.1). Oxygen inhibited 
adenosine-induced increases in HR and MSNA (from +305 ± 99 to +198 ± 75 units/100 beats and from +26 ± 4 to 
+18 ± 3 beats/min;p < 0.05 for both comparisons). The MSNA response to these combined stimuli was similar to that 
observed during LBNP. In contrast, the residual HR response (+18 ± 3 beats/min) was significantly greater than the response 
to LBNP (+2 ± 2 beats/min; p < 0.05). These data indicate that arterial baroreceptor unloading cannot account for the marked 
adenosine-induced increase in HR, but may be sufficient to explain its effect on MSNA. The effect of 100% oxygen confirms 
that stimulation of carotid chemoreceptors accounts for approximately one-third of the HR and MSNA response to adenosine. 
However, other mechanisms, such as stimulation of adenosine-sensitive afferent nerves in other vascular beds, are involved in 
the HR and possibly the MSNA response.
Key words: adenosine, human, heart rate, sympathetic nervous system, baroreflex.
Résumé : L ’adénosine augmente la fréquence cardiaque et l’activité nerveuse sympathique de manière réflexe chez les
humains conscients et ce, par 1*intermédiaire de divers mécanismes. Le but de la présente étude a été d’évaluer l’influence sur
ces réponses d’une décharge des barorécepteurs artériels, d’une stimulation des chémorécepteurs carotidiens, ainsi que
d’autres nerfs afférents sensibles à Padénosine. Chez 12 hommes sains, on a comparé l’effet d ’une pression négative des
membres inférieurs (PNMI; -15 mmHg (1 mmHg = 133,3 Pa)) avec celui de Padénosine intraveineuse (35, 70 et
140 jig-kg^-mür1) sur la pression artérielle, la fréquence cardiaque (FC) et l’activité nerveuse sympathique musculaire
(ANSM; nerf périonnier). Chez huit sujets, on a réinjecté la plus forte dose d’adénosine en présence de 100% d’oxygène afin
de supprimer les chémorécepteurs artériels. Les réductions de pression artérielle durant la PNMI et l’adénosine
(140 |Xg-kg_1-min_I) ont été similaires. La fréquence cardiaque n’a pas changé significativement durant la PNMI
(+2 ± 2 battements/min; moyenne ± ÉT), mais elle a augmenté à la plus forte dose d’adénosine (+25 ± 3 battements/min;
p < 0,05). L5ANSM a augmenté significativement (p < 0,05) durant les deux interventions (+225 ± 82 et
247 ± 58 unités/100 battements pour Padénosine et la PNMI, respectivement); de plus, il n ’y a eu aucune différence dans la
réponse de l’ANSM à ces deux stimuli (p > 0,1). L’oxygène a inhibé les augmentations de FC et d’ANSM induites par
Padénosine (de + 3 0 5 ± 9 9 à l9 8 ± 7 5  unités/100 battements et de +26 ± 4 à +18 ± 3 battements/min; p < 0,05 dans les deux
cas). La réponse de I’ANSM à ces deux stimuli combinés a été similaire à celle observée durant la PNMI. À l’opposé, la
réponse FC résiduelle (+18 ± 3 battements/min) a été significativement plus forte que la réponse à la PNMI
(+2 ± 2 battements/min; p < 0,05). Ces résultats indiquent que la décharge des barorécepteurs artériels ne peut justifier
l’augmentation de FC marquée induite par Padénosine, mais elle pourrait être suffisante pour expliquer son effet sur l’ANSM.
L’effet obtenu en présence de 100% d’oxygène confirme que la stimulation des chémorécepteurs carotidiens contribue à
environ un tiers de la réponse de PANSM et de la FC à l’adénosine. Toutefois, d’autres mécanismes, tels que la stimulation
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des nerfs afférents sensibles à Padénosine dans d’autres lits vasculaires, participent à la réponse de la fréquence cardiaque et 
possiblement de TANSM.
Mots clés : adénosine, humain, fréquence cardiaque, système nerveux sympathique, baroréflexe.
[Traduit par la Rédaction]
Introduction
The arterial vasodilator actions of adenosine (Smits et al. 
1990) have stimulated its use in stress radiotracer imaging for 
the evaluation of patients presumed to suffer myocardial is- 
chemia (Cerqueira et al. 1994). However, adenosine has, in 
addition, complex and often opposing effects on the cardiovas­
cular and autonomic nervous systems (Rongen et aL 1997). 
Adenosine inhibits norepinephrine release from sympathetic 
nerve endings via a presynaptic mechanism (Kubo and Su 
1983; Rongen et al. 1996), and has negative chronotropic, ino­
tropic, and dromotropic effects on the heart (Belardinelli and 
Berne 1989). These properties have found application in the 
treatment of supraventricular tachycardias (DiMarco et al. 
1983). These direct effects are mediated by adenosine recep­
tors located on the effector cells.
In contrast with these inhibitory direct effects, intravenous 
adenosine infusion in conscious humans elicits a sympatho- 
excitation that is accompanied by tachycardia and hyperventi­
lation (Fuller et al. 1987; Clarke et al, 1988; Maxwell et al. 
1987; Watt et al. 1989). The mechanism or mechanisms re­
sponsible for these changes have not been completely eluci­
dated. The purpose of the present study was to assess the 
relative contributions of arterial baroreceptor unloading, ca­
rotid chemoreceptor stimulation, and other adenosine- 
sensitive afferent nerves to these responses. Biaggioni et al. 
(1991a) observed less increase in muscle sympathetic nerve 
activity (MSNA) in response to intravenous sodium nitroprus- 
side compared with adenosine when infused in doses causing 
similar reductions in diastolic blood pressure, suggesting that 
the marked increase in MSNA during adenosine infusion was 
due to mechanisms other than arterial baroreceptor unloading. 
However, at the time of these experiments it was not appreci­
ated that sodium nitroprusside, as a nitric oxide donor, could 
inhibit efferent sympathetic outflow at brainstem or other sites 
(Sakuma et al. 1992; Bredt et al 1990). Thus, the relative con­
tribution of the arterial baroreflex to this adenosine-mediated 
sympathoexcitatory reflex remains uncertain.
Because the excitatory effects of exogenous adenosine can 
be blunted by breathing 100% oxygen (Biaggioni et al. 1987), 
activation of chemoreceptors in the carotid body was thought 
to be the principal stimulus to this excitatory reflex. However, 
the sympathoexcitatory effects of adenosine uptake inhibition 
are not abolished completely by 100% oxygen (Engelstein 
et al. 1994). Other adenosine-sensitive afferent nerves have 
been recently identified in the human forearm; these may also 
be present in the heart and kidney (Katholi et al. 1984; Biag­
gioni et al. 1987; Cox et al. 1989; Watt et al. 1987; Costa and 
Biaggioni 1993; Thames et al. 1993). When stimulated, these 
afferents increase efferent sympathetic nerve traffic to muscle, 
an action that likely contributes to these reflex excitatory re­
sponses to intravenous adenosine.
This investigation was performed to elucidate a possible 
contributory role for arterial baroreflex unloading in the
adenosine-induced activation of the sympathetic nervous sys­
tem in conscious humans, using a nonpharmacological hypo­
tensive stimulus for comparison. We administered adenosine 
doses that are used for clinical purposes, e.g., the adenosine- 
thallium stress test for cardiac ischemia (Cerqueira et al, 
1994). The effects of intravenous adenosine were compared 
with responses to lower body negative pressure (LBNP), a 
maneuver that initially deactivates cardiopulmonary baro- 
receptors, and at higher negative pressures aortic and carotid 
arterial baroreceptors. An LBNP o f -15 mmHg (1 mmHg = 
133.3 Pa) was applied because this stimulus was expected to 
have effects on blood pressure closely resembling those of 
adenosine (Floras 1990). (A potential alternative intervention, 
namely neck pressure, would be unsuitable for the purpose of 
this experiment, as this maneuver elicits only transient in­
creases in MSNA: 1-2 s, despite continuation of this stimulus 
(Wallin and Eckberg 1982)), The effect of carotid chemo­
receptor inhibition, by inhalation of 100% oxygen, on 
adenosine-induced changes in hemodynamics and MSNA was 
also examined.
Methods
Subjects
After approval of this protocol by our institutional ethics committee, 
12 healthy male volunteers (mean age 48 years; range 31-56 years) 
were recruited for this study. Subjects signed written consent forms 
before their participation. They had no history of cardiac or pulmo­
nary disease and none were taking medication. Baseline hemody­
namic and neural variables are given in Table 1.
Procedures
All experiments were performed in the morning, after an overnight 
fast with subjects lying supine. Subjects were instructed to abstain 
from caffeinated beverages on the morning of the experiment. Caf­
feine abstinence of this brief duration has no effect on diastolic blood 
pressure, the proximate simulus to a subsequent burst of MSNA 
(Sanders and Ferguson 1989), or on heart rate (G.A, Rongen,
S.C. Brooks, S. Ando, B.L. Senn, C,L. Notarius, and J.S. Floras, to be
published).
Blood pressure was measured at 1-min intervals by an automatic 
cuff recorder (model Lifestat 200, Physio-Control, Redmond, Wash.). 
Heart rate (electrocardiography) was recorded continuously and si­
multaneously with the sympathetic mean voltage neurogram (model 
2800S ink recorder, Gould, Cleveland, Ohio).
Postganglionic multifiber SNA was recorded from a muscle fasci­
cle of the right peroneal nerve posterior to the fibular head, using a 
microneurographic technique (Delius etal. 1972; Floras et aL 1987). 
Recordings were made with tungsten micro electrodes with a 200-|am 
shaft diameter, tapering to a 1- to 5-jam uninsulated tip, A reference 
electrode was inserted subcutaneously 1 to 3 cm from the recording 
electrode. Electrodes were connected to a preamplifier with a gain of 
1000 and an amplifier with a gain that could be varied from 30 to 90 
as required in a subject. Amplification was constant throughout the 
study in each subject. Neural activity was fed through a bandpass 
filter with a bandwidth of700 to 2000 Hz. The filtered neurogram was 
routed through an amplitude discriminator to a storage oscilloscope
© 1997 NRC Canada
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Table 1. Baseline hemodynamic and neural characteristics of the healthy subjects.
Note: Values are means ± SE.
*p< 0,05 versus baseline before LBNP.
fp < 0.05 versus baseline before adenosine without 100% oxygen (Wilcoxon paired signed rank test).
Variable
Baseline before
LBNP
Baseline before 
adenosine infusion
Baseline before adenosine 
infusion with 100% oxygen
n 12 12 8
Systolic blood pressure (mmHg) 120.0±2.0 122.7±2.1 122.6±2.7
Diastolic blood pressure (mmHg) 76.0+1.9 76.5±2.0 77.6±2.1
Heart rate (beats/min) 66,0±3.8 63.5+3.4* 58.3±3.3*f
Sympathetic nerve activity
Bursts/min 41.9+5.1 39.7+4.3 37.5+4.6
Bursts/100 beats 60.9±4.3 60.5±4.3 63.4±5.5f
Arbitrary units 392.2+77.6 356.8+79.5 408.1±132.7
Arbitrary units/100 beats 552.9+87.3 531.2+109.0 668.212042______
and a loudspeaker. For recording and analysis, the filtered neurogram 
was fed through a resistance-capacitance integrating network (time 
constant, 0.1 s) to obtain a mean voltage neurogram of SNA. There 
were three criteria for an acceptable recording of muscle SNA. First, 
weak electrical stimulation (1-10 V, 0.2 ms, 1 Hz) through the elec­
trode in the peroneal nerve elicited involuntary muscle contraction but 
not paresthesiae. Second, tapping or stretching the muscle or tendons 
supplied by the impaled fascicle elicited afferent mechanoreceptor 
discharge, whereas stroking the skin in the distribution of the peroneal 
nerve did not. Third, the neurogram contained spontaneous, intermit­
tent, pulse-synchronous bursts that increased during held expiration. 
Evidence from earlier studies that such activity represents efferent 
postganglionic sympathetic activity includes (/) interruption of activ­
ity by local nerve block proximal but not distal to the recording site, 
(if) reversible elimination of activity by ganglionic blockade, and 
(iii) a conduction velocity approximating 1 m/s,
Protocol
Ten to fifteen minutes after instrumentation, the experiment started 
with 6-min baseline measurements, immediately followed by a 6-min 
LBNP at -15 mmHg. Approximately 30 min thereafter, a 4-min base­
line period was repeated, immediately followed by 4-min infusions of 
adenosine (Fujisawa Inc., Markham, Ont.), in 0.9% saline, at sequen­
tial doses of 35, 70, and 140 jug-kg^-min“1. Fifteen minutes after the 
last adenosine infusion, 100% oxygen was delivered by a non­
rebreathing oxygen mask (Respan Products Inc., Erin, Ont.). After a 
4-min baseline period, the highest adenosine dose (140 ¡ag'kg^-mur1) 
was reinfused during administration of 100% oxygen.
The intervals of 30 and 15 min between LBNP and adenosine and 
adenosine with and without inhalation of 100% oxygen, respectively , 
allowed heart rate and MSNA to return to baseline.
Statistics
Muscle SNA was expressed as integrated MSNA (units/100 beats): 
the product of burst incidence (bursts/100 beats) and averaged burst 
amplitude. Since muscle sympathetic bursts occur pulse synchro­
nously, maximum burst frequency is dictated by heart rate (Delius 
et al. 1972; Sundlof and Wallin 1977). Adenosine increases heart rate, 
thereby increasing burst frequency nonspecifically (Fig. 1). To o vercome 
this problem, we used integrated burst incidence (bursts/100 beats) 
instead of burst frequency to express MSNA. For each variable, all 
baseline measurements were averaged to obtain a single value. During 
LBNP and adenosine infusion, mean values for each subsequent 
2-min period were derived from all measurements obtained during 
these time periods. The effects of LBNP or adenosine during each 
2-min period were calculated as differences from baseline. Since the 
response to adenosine reached its maximum after the first 2 min, only
the results of the last 2 min of each adenosine dose are presented. For 
the comparison of LBNP with adenosine, the three subsequent 2-min 
values for responses were averaged to one value for each variable. If 
Friedman nonparametric two-way ANOVA for repeated measures 
was statistically significant, Wilcoxon paired signed rank tests were 
performed to determine the particular time interval (LBNP) or adeno­
sine dose at which statistical significance was achieved. Differences 
between LBNP and adenosine and differences between adenosine 
with and without concomitant 100% oxygen breathing were analyzed 
using the Wilcoxon paired signed rank test. Results are expressed as 
mean ± SE. Values ofp  < 0.05 were considered statistically significant.
Results
LBNP and adenosine infusions were completed in all 12 sub­
jects. In four volunteers, the last part of the experiment (100% 
oxygen breathing) was not performed because the MSNA re­
cording site was lost or because of volunteer discomfort (chest 
pain, flushing, or dyspnea).
Apart from a small difference in heart rate and sympathetic 
nerve activity when expressed as bursts/100 beats, baseline 
variables were similar prior to the three procedures (Table 1).
Hemodynamic and neural effects of LBNP
During LBNP, systolic blood pressure decreased by a maxi­
mum of 5 ± 1 mmHg, from 120 ± 2 mmHg at baseline to 115 ± 
2 mmHg, 4 min after starting this maneuvre (p < 0.01; Fig. 1). 
Likewise, diastolic blood pressure decreased by 3 ± 1 mmHg, 
from 76 ± 2 mmHg at baseline to 73 ± 2 mmHg, at 2 min after 
the start of the LBNP (p < 0.05). There was a modest 3 ± 
2 beats/min increase in heart rate from 66 ± 4 beats/min at 
baseline to 69 ± 4 beats/min 4 min after start of LBNP 
(p=  0.1). MSNA increased significantly, by 224 ± 63 
units/100 beats, 2 min after the start of the LBNP (p < 0.01; 
Fig. 2).
Hemodynamic and neural effects of adenosine
An individual tracing during baseline and adenosine infusion 
is shown in Fig. 1. Adenosine infusion had nonsignificant ef­
fects on systolic blood pressure (-3 ± 2 mmHg during the 
highest infusion rate; p  = ns; see Fig. 2), but it reduced dia­
stolic blood pressure by 3 ± 1 mmHg during the highest infu­
sion rate (p < 0.05). Heart rate increased dose-dependently by 
a maximum of 25 ± 3 beats/min during the highest infusion
© 1997 NRC Canada
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Fig. 1. Individual tracing illustrating the response to three infusions of adenosine in a single volunteer. Continuous arterial blood pressure was 
recorded from the finger in this volunteer for illustrative purposes (Finapres, Ohmeda). The tracing clearly shows the pulse synchronicity of 
MSNA. Changes in burst frequency and amplitude are preceded by opposite fluctuations in blood pressure, which illustrates the importance of 
the arterial baroreflex in spontaneous modulations in MSNA. Heart rate and fmger systolic blood pressure increased in this particular 
experiment, which was performed in a subject who voluntarily abstained from caffeine for 24 h before the study.
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rate (p < 0.01). Likewise, MSNA increased dose-dependently 
by a maximum of 255 ± 82 units/100 beats during the highest 
infusion rate (p < 0.05; see Fig. 1).
During the highest adenosine infusion rate, the blood pres­
sure reduction and increase in MSNA were not significantly 
different from the peak responses observed during LBNP (see 
Fig. 3). In contrast, the heart rate response was significantly 
higher during adenosine compared with LBNP (+25 + 3 versus 
+2 ± 2 beats/min for adenosine and LBNP, respectively; 
p  < 0.05).
Effect of breathing 100% oxygen on the hemodynamic 
and neural effects of adenosine
In eight subjects, the highest adenosine infusion was repeated 
during inhalation of 100% oxygen (see Fig. 4). Responses of 
systolic and diastolic blood pressure to adenosine were not 
significantly affected by breathing 100% oxygen. The re­
sponse in heart rate was significantly reduced but not com­
pletely abolished: +26 ± 4 versus +18 ± 3  beats/min 
(p < 0.05). A comparable result was obtained when heart rate 
responses were expressed as percent change from baseline. 
Likewise, breathing oxygen significantly reduced the response 
in MSNA: +305 + 99 versus +198 ± 75 units/100 beats
(p < 0.05). The residual MSNA response during 100% oxygen 
breathing remained significantly different from baseline 
(p = 0.05). Compared with LBNP in these subjects, adenosine 
with concomitant breathing of 100% oxygen induced similar 
reductions in blood pressure, a similar increase in MSNA, but 
a greater increase in heart rate (Fig. 5; +17.5 ± 3.4 versus 
+1.6 ± 1.9 beats/min for adenosine and LBNP, respectively; 
p <  0.05).
Discussion
In this study, adenosine-induced changes in blood pressure, 
heart rate, and MSNA were compared with the effects of me­
chanical unloading of baroreceptors. The major new finding of 
this study is that adenosine but not LBNP induced an increase 
in heart rate, while both interventions induced similar changes 
in blood pressure and sympathetic nerve traffic, Thus, while 
arterial baroreceptors were deactivated to a similar extent dur­
ing both interventions, the response in heart rate differed mark­
edly, indicating that the adenosine-induced increase in heart 
rate cannot be explained by unloading of arterial barorecep­
tors. Inhalation of 100% oxygen significantly inhibited the ef­
fect of adenosine on sympathetic nerve traffic and heart rate,
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Fig. 2. Time course in blood pressure (SBP, systolic blood 
pressure; DBP, diastolic blood pressure), heart rate (HR), and 
MSNA responses to LBNP, and dose-response curve for the same 
variables during graded intravenous infusion of adenosine. 
*Responses statistically significantly different from zero (n = 12).
LBNP (-15 mmHg) Adenosine
0)</> c  o o>
Ql  X  
if) c  Q> tu  r
ClCÛ
CO
Q>U>C ^  
Q ö) 
Q- T
if) 7=
0) E 
ECLCQÛ
Û) ^  
(/> Cc  •= O £
s*
S ra
.a
X
a> w
g ™o £nl/> QEí o
c£ CS i/>
co §
Time (min) Adenosine dosage
(fjg’kg"1*mln"1)
indicating that activation of peripheral chemoreceptors is par­
tially responsible for this response to adenosine.
The hemodynamic response to intravenous adenosine in 
humans has been studied in considerable detail. Adenosine 
induces a dose-dependent increase in heart rate and stroke vol­
ume and reduces diastolic blood pressure and total peripheral 
resistance, mainly by vasodilation of skin and splanchnic 
vascular beds (Biaggioni et al, 1991a; Edlund et a l 1990; 
Nussbacher et al. 1995; Smits et al. 1987a). The other inter­
vention, LBNP of-15 mmHg, reduces central venous pressure 
and stroke volume, and to a lesser extent increases peripheral 
resistance, resulting in modest hypotension (Floras 1990).
In the present study, the drop in blood pressure was small,
,-ibut similar during LBNP and adenosine at 140 jxg-kg^-min 
indicating that arterial baroreceptors were probably deacti­
vated equally. Notwithstanding, heart rate increased during 
adenosine but not during LBNP, indicating that arterial barore- 
ceptor unloading is probably not involved in the adenosine- 
induced increase in heart rate. A reduction of parasympathetic 
tone contributes to this chronotropic response (Conradson 
et al. 1987a), We cannot exclude an additional effect of adeno­
sine on baroreceptor reflex sensitivity, with subsequent aug­
mentation of the heart rate response to arterial baroreceptor 
unloading. However, in conscious dogs, adenosine actually 
reduces the heart rate response to a fall in blood pressure,
Fig* 3. Comparison between LBNP and adenosine 
(140 jxg*kg~1-min~l). ^Responses statistically significantly different 
from baseline. Values of p indicate level of significance for 
difference between LBNP and adenosine (n = 12).
0)«c — o O)
Q. XV) CCD cr 
00
0
•1
-2
-3
-4
-5
-6
0
coc  ^  o OÎ
O - X
CO 
CD
§5Û
E
E
0
-1
-2
-3
-4
-5
-6
p=ns
p<0.05
0) to c 
o
8* M
c
E
30
25
20
15
10
5
0
<D 'w
co ££ 
c  ctio <1)Q. X3
Q) g  
u. O
< 54-i
( / )  C 3
400
300
200
100
0
LBNP (-15 mmHg) 
Adenosine, MOjug-kg^-mln'1
Fig. 4. Effect o f 100% oxygen breathing on the effects of adenosine 
(140 fig‘kg"l*min_1). Values of p indicate level of significance for 
effect of oxygen on responses to adenosine (n -  8).
CDW
CO 0> 
Q*
to c
a.
COco
0
-1
■2
-3
-4
-5
*6
<D 
co cO O) 
Q. T  (/)0
CL
CQ Q
0
"1
-2
-3
-4
-5
-6
a)to c c  -~o  E
Cl
to  to2 to
r r  03
«A»
40
30
204
10
o
p<0,05
I------ 1
_r
0<0co
Q.(0a>
¿2
cda)n
oo
< §
Z  .t:
C/D c2 3
500
400
300
200
100
0
U
p=ns
p < 0 .0 5
Adenosine, ^O /jg -kg ^ -m in '1
Adenosine, 140/ig-kg^-m in-1, + 100% oxygen breathing
probably by its direct negative chronotropic action on the 
sinoatrial node (Hintze et al. 1985).
Breathing 100% oxygen was used to inhibit peripheral 
chemoreceptors. This intervention significantly reduced the 
response of both heart rate and MSNA to adenosine, confirm­
ing tlie involvement of chemoreceptors in these effects. How­
ever, a significant residual increase in both variables persisted 
during oxygen. Arterial oxygen tension of approximately 
400 mmHg is associated with complete inhibition of chemore­
ceptors (Biscoe et al. 1970). We did not sample arterial blood 
to determine the efficacy of oxygen delivery, but in one vol­
unteer end-expiratory oxygen tension was over 700 mmHg, 
suggesting that the oxygen administration in these experiments 
was sufficient to abolish chemoreceptor activation completely. 
Since the response in MSNA did not differ significantly be­
tween LBNP and adenosine, involvement of the baroreflex 
could still account for the residual increase in MSNA but not 
for the residual heart rate response, since this was markedly 
different from the response to LBNP. Adenosine increases 
tidal volume (Fuller et al. 1987; Watt et al. 1987; Smits et al. 
1987b) and thereby stimulates pulmonary stretch receptors. 
However, the heart rate response to adenosine is not affected
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Fig. 5. Comparison between LBNP and adenosine
(140 Jig-kg^-min"1) with concomitant breathing of 100% oxygen.
*Responses statistically significantly different from baseline.
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by pulmonary denervation in humans, indicating that these 
receptors are not involved in the heart rate response to adeno­
sine (Morgan-Hughes et al. 1994). Adenosine-sensitive 
sympathetic efferents in heart, kidney, and (or) skeletal muscle 
(Katholi et al. 1984; Cox et al. 1989; Costa and Biaggioni 
1993; Thames et al. 1993; Edlund et al. 1994) are probably 
resistant to oxygen administration and could be involved in the 
adenosine-induced heart rate increase.
Some possible limitations of this study should be discussed. 
First, we did not measure cardiac filling pressures. Therefore, 
we cannot exclude the possibility that LBNP and adenosine 
infusion differentially unloaded cardiopulmonary barorecep- 
tors. Others have shown that adenosine (80 (Xg-kg_1*min-1) 
does not affect central venous pressure of young healthy vol­
unteers (Biaggioni et al. 1991a). hi patients who were studied 
during a diagnostic catheterization, intravenous adenosine 
(140 jig-kg^-min“1) caused a modest (1.6 mmHg) increase in 
right atrial pressure (Nussbacher et ai. 1995). In contrast, pre­
vious studies from our laboratory have demonstrated that cen­
tral venous pressure drops by approximately 5 mmHg in 
response to an LBNP of-15 mmHg (Floras 1990). Others have 
shown that application of less negative pressure, which was 
not accompanied by a reduction in arterial blood pressure and 
thus probably unloaded cardiopulmonary baroreceptors selec- 
tively, increased MSNA by approximately 60-70% (Oren 
et al. 1993; Victor and Leimbach 1987). Thus, cardiopulmon­
ary baroreceptor unloading probably accounted for most of the 
LBNP-induced increase in MSNA but none of the effects of 
adenosine on MSNA. The relatively equivalent effect on 
MSNA of LBNP and of adenosine, in the presence of 100% 
oxygen, argues that stimulation of other adenosine-sensitive 
afferents (kidney, heart, skeletal muscle), not directly related 
to the baroreflex, causes a sympathoexcitation that is roughly 
similar to that of cardiopulmonary baroreceptor unloading 
during LBNP.
A second limitation of the study is related to the relatively 
short period of caffeine abstinence advised our subjects. Caf­
feine is an adenosine receptor antagonist in humans in vivo 
(Smits et al. 1987a; Biaggioni et al. 19916). In studies in 
healthy volunteers with less than 12-24 h of caffeine
abstinence, systolic blood pressure does not increase (Watt 
et al. 1987, 1989; Conradson et al. 1987a, 19876; Fuller et al. 
1987; Clarke et al. 1988; Maxwell et al. 1987; Rongen et al. 
1995), whereas in otherwise comparable studies with caffeine 
abstinence of more than 24 h systolic blood pressure invari­
ably rises (Smits et al. 1987a; Biaggioni et al. 1987, 1991a, 
19916; Edlund et al. 1990; Reid et al, 1987). Since caffeine 
abstinence was for approximately 12 h in most of our volun­
teers, the interaction between caffeine and adenosine probably 
explains why their systolic blood pressure fell. This probably 
also explains why the increase in MSNA in our present study 
was less than in a previous report by others who studied the 
effect of adenosine after at least 24 h of caffeine abstinence 
(Biaggioni et al. 1991a). A 12- to 24-h caffeine abstinence 
period is consistent with the current clinical practice in nuclear 
medicine where adenosine infusion (140 ¡J-g-kg'^min"1) is 
used for the evaluation of cardiac ischemia. Our study shows that 
adenosine- induced sympathoexcitation can occur in the clini­
cal setting of adenosine-thallium scanning. These increases in 
sympathetic nerve traffic to the heart and peripheiy may have 
adverse implications for patients with ischemic heart disease.
In conclusion, the adenosine- evoked increase in heart rate 
was not observed during a LBNP stimulus that reduced arterial 
blood pressure to a similar extent. MSNA was equally in­
creased during LBNP and adenosine infusion. These observa­
tions indicate that arterial baroreceptor unloading is probably 
not involved in the heart rate response to adenosine. Oxygen 
partially inhibited the increase in heart rate and MSNA, con­
firming the involvement of chemoreceptors in this response to 
adenosine, Other well-documented adenosine-sensitive sym­
pathetic afferents may be involved in the residual heart rate 
response.
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